Yes, I agree,we as shareholders,on HC have been far more conservative (justifiably been assuming mortality rate of 35% - 40%),
FG and SI used 60%-80% mortality with current SOC in our target patient group, SI also said they were being more conservative but followed up with the statement about if we show the same level of success in Mt Sinai we won't need to complete the trial (I choked on my weetbix when I heard that).
They sounded extremely confident, if this confidence is justified it is HUGE for MSB!
Ann: Annual Financial Results Presentation, page-33
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |